Russell Frank Company’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q1
$2.76M Buy
93,781
+20,552
+28% +$604K ﹤0.01% 1687
2015
Q4
$2.45M Sell
73,229
-4,424
-6% -$148K ﹤0.01% 1711
2015
Q3
$2.81M Buy
77,653
+8,088
+12% +$292K 0.01% 1646
2015
Q2
$3.13M Buy
69,565
+57,979
+500% +$2.61M 0.01% 1717
2015
Q1
$355K Sell
11,586
-39,513
-77% -$1.21M ﹤0.01% 2499
2014
Q4
$2.61M Buy
51,099
+5,662
+12% +$289K ﹤0.01% 1633
2014
Q3
$1.8M Sell
45,437
-1,596
-3% -$63.2K ﹤0.01% 1792
2014
Q2
$1.77M Buy
47,033
+4,427
+10% +$167K ﹤0.01% 1821
2014
Q1
$1.59M Buy
42,606
+2,460
+6% +$92K ﹤0.01% 1876
2013
Q4
$1.47M Buy
40,146
+40,126
+200,630% +$1.47M ﹤0.01% 1891
2013
Q3
$0 Buy
+20
New ﹤0.01% 3458